Results 231 to 240 of about 31,523 (247)

Clinical and immunologic features of chronic dialysis patients who fail to respond to hepatitis B vaccine

Vaccine, 1985
Eighteen patients on chronic dialysis (15 haemodialysis, three peritoneal) were evaluated to determine whether certain clinical features and/or in vitro indicators of immune function correlated with the response to hepatitis B vaccine. Only 44% of patients developed antibody to hepatitis B surface antigen (anti-HBS) following vaccination and neither ...
F G, Regenstein, R P, Perrillo, C, Bodicky, K, Stern, S, Zelman   +4 more
openaire   +2 more sources

IMMUNOLOGICAL CONSEQUENCES OF HIV INFECTION: ADVANTAGE OF BEING LOW RESPONDER CASTS DOUBTS ON VACCINE DEVELOPMENT

The Lancet, 1988
Immunosuppression in AIDS might be due to the immune response rather than to the pathogenicity of the virus. The basis of the immunosuppression could be molecular mimicries involving viral gp-110, CD4 molecules, antibodies, and CD4-acceptor sites. Whether an individual develops auto-immunosuppressive responses or mounts a harmless defence against (or ...
C, Martínez-A, M A, Marcos, A, de la Hera, C, Marquez, J M, Alonso, M L, Toribio, A, Coutinho   +6 more
openaire   +2 more sources

Immunological regulation of experimental cutaneous leishmaniasis. 2. Studies with Biozzi high and low responder lines of mice

Parasite Immunology, 1981
SUMMARYSusceptibility to Leishmania tropica was studied in Biozzi‘high’(Ab/H) and‘low’(Ab/L) responder mice of Selections I and III which, although originally selected with heterologous erythrocytes and Salmonella flagellar antigens respectively, both show non‐specific separation of antibody responses.
C, Hale, J G, Howard
openaire   +2 more sources

HIV reservoir dynamics in HAART-treated poor immunological responder patients under IL-7 therapy

AIDS, 2018
Recombinant Human IL-7 (rhIL-7) therapy allows reconstituting systemic and tissue-associated CD4 T-cell populations in HIV-infected poor immunological responder (PIR) patients. However, in-vitro studies suggest that the impact of rhIL-7 treatment on HIV-DNA loads in vivo remains questionable.We assessed the dynamics of circulating HIV-DNA loads in IL-7-
Logerot, Sandrine, Rancez, Magali, Charmeteau-de Muylder, Bénédicte, Figueiredo-Morgado, Suzanne, Rozlan, Sandra, Tambussi, Giuseppe, Beq, Stéphanie, Couëdel-Courteille, Anne, Cheynier, Rémi   +8 more
openaire   +3 more sources

CD4+ T lymphocyte recovery in the modern antiretroviral therapy era: Toward a new threshold for defining immunological non-responders

Frontiers in Virology, 2023
Mauro Giacomini, Lucia Taramasso, Antonio di Biagio   +2 more
exaly  

Immunological Findings in a Group of Individuals Who Were Poor or Non-Responders to Standard Two-Dose SARS-CoV-2 Vaccines

Vaccines, 2023
Qiang Zeng
exaly  

Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination

Frontiers in Immunology, 2022
Natalia Garcia-Giralt, Güerri-Fernandez R, Marta Sisteré   +2 more
exaly  

Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapy

HIV Research and Clinical Practice, 2020
Mohammad-Ali Jenabian, Kim Engler, Jean-Pierre Routy   +2 more
exaly  

Active lymphocytic myocarditis: virologic and immunologic profile of responders versus non-responders to immunosuppressive therapy

2001
CHIMENTI, CRISTINA, M. Pieroni, F. Calabrese, R. Verardo, G. Thiene, A. Maseri, FRUSTACI, ANDREA   +6 more
openaire   +5 more sources

#56 Endocrine, autonomic, and immunological changes in response to the TSST: Comparison between TSST responders and non-responders in healthy subjects and fibromyalgia patients

Brain, Behavior, and Immunity, 2005
Judith Hesse, Andrea C. Gierens, Dirk H. Hellhammer   +2 more
openaire   +1 more source